| Code | 4949E | ||||||||||
| MA number | 59/0220/23-S | ||||||||||
| Product Form: | tbl flm 84x14 mg (blis.OPA/Al/PVC//papier-Al - kalend.bal.) | ||||||||||
| MA Status: | R - Valid Marketing Authorisation | ||||||||||
| Type of procedure: | Decentralised | ||||||||||
| Therapeutic Class: | 59 - IMMUNOPRAEPARATA | ||||||||||
| ATC: |
|
||||||||||
| Shelf life: | 24 | ||||||||||
| Route of admin.: | Oral use |
| Prescription Status: | Medicinal product subject to restricted medical prescription. |
| Legal basis: | Article 10(1) generic application |
| MA issued: | 07.11.2023 |
| Validity: | 07.11.2028 |
| Pediatric indication: | Yes |
| Pediatric posology: | Yes |
| Pediatric warnings: | Yes |
| SPC: |
SPC_Teriflago 14 mg filmom obalené tablety_tbl flm_11/2023_REG.pdf
|
| PIL: |
PIL_Teriflago 14 mg filmom obalené tablety_tbl flm_11/2023_REG.pdf
|
| Safety feature | Yes |
| Data update: | 14.11.2023 |
